Uveitis: A Potentially Blinding Disease
- 6 July 2004
- journal article
- review article
- Published by S. Karger AG in Ophthalmologica
- Vol. 218 (4) , 223-236
- https://doi.org/10.1159/000078612
Abstract
Uveitis (intraocular inflammation) is a potentially blinding group of, probably autoimmune, conditions predominantly occurring in the working age group. Although the aetiology is unknown in most cases, many patients have an associated underlying systemic disease. Central vision loss, in the form of cystoid macular oedema, is the commonest type of visual impairment. Although historical incidence and prevalence data exists, little is known about the degree of vision loss experienced, and the social and financial consequences of having temporary or permanent visual impairment in this age group. The literature is also full of uncontrolled studies and case reports of different modalities of drug therapy for uveitis. This article attempts to raise the awareness of uveitis as an important sight-threatening group of conditions by highlighting the paucity of evidence-based data on epidemiological, quality of life, socioeconomic, and therapeutic aspects. Copyright (C) 2004 S. Karger AG, Basel.Keywords
This publication has 58 references indexed in Scilit:
- Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administrationJournal of Autoimmunity, 2003
- Treatment of ocular inflammatory disorders with daclizumabOphthalmology, 2003
- Efficacy and safety of chlorambucil in intractable noninfectious uveitisOphthalmology, 2002
- Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic respondersBlood, 2001
- Intravenous immunoglobulin therapy for resistant ocular Behcet's diseaseBritish Journal of Ophthalmology, 2001
- Short-term chlorambucil for refractory uveitis in Behcet's diseaseOcular Immunology and Inflammation, 2001
- Long-Term Effects of Interferon Alpha 2A Treatment in Behçet’s DiseaseDermatology, 2000
- Regular review: Management of chronic uveitisBMJ, 2000
- Uveitis in childrenOcular Immunology and Inflammation, 2000
- Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporineOphthalmology, 1999